LucyDx
LucyDx, with a valuation of $8 million, is raising funds on NetCapital. It is a medical technology company developing a diagnostic headset for the early detection of diabetic retinopathy. The non-invasive and compact headset of LucyDx is based on an electroretinogram and aims to prevent blindness through early detection. LucyDx has pinpointed its target market, validated demand, and is working with researchers at Emory University, Georgia Tech, and the VA Atlanta Medical Center. Andreas Inmann and Antoin Johnson founded LucyDx in February 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, regulatory affairs, operations and payroll, prototyping, and testing.
LucyDx, with a valuation of $8 million, is raising funds on NetCapital. It is a medical technology company developing a diagnostic headset for the early detection of diabetic retinopathy. The non-invasive and compact headset of LucyDx is based on an electroretinogram and aims to prevent blindness through early detection. LucyDx has pinpointed its target market, validated demand, and is working with researchers at Emory University, Georgia Tech, and the VA Atlanta Medical Center. Andreas Inmann and Antoin Johnson founded LucyDx in February 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, regulatory affairs, operations and payroll, prototyping, and testing.
Stay in the Loop
Get updates from LucyDx
Get exclusive updates from LucyDx
Be the first to know about company milestones, news, and opportunities.
🔒 No spam. Just real progress.
Company Stats
Key metrics about LucyDx
Are you the owner of LucyDx?
Claim your company profile to respond to reviews, update your information, and connect with investors.
Claim This Company